{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:23:52Z","timestamp":1790115832488,"version":"4.0.1"},"reference-count":42,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective.<\/jats:title>\n                    <jats:p>The assessment of the cardiovascular (CV) risk is recommended in patients with chronic inflammatory rheumatic diseases. The objectives of this study were to assess the CV risk profile in a cohort of patients with psoriatic arthritis (PsA), to determine the presence of subclinical cardiovascular disease by carotid ultrasound (US), and to study the association of CV disease to PsA characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>This was a cross-sectional multicentric descriptive study. The clinical CV risk was calculated with Systematic Coronary Risk Evaluation (SCORE) charts. Common carotid US was conducted to evaluate the carotid wall intima-media thickness and the presence of atheroma plaques. Patients were reclassified upon US results. Multivariate analyses were performed to identify associations of US carotid abnormalities with the classical CV risk factors and PsA characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>The study included 176 patients with PsA. The SCORE-estimated CV risk was intermediate in 65.3% of the patients. In the US study, 32% of the patients had abnormalities, and 30.8% of the patients were upgraded and reclassified as very high risk owing to the presence of atheroma. Subclinical CV disease was associated with age and dyslipidemia but not with other risk factors. It was associated with axial disease in the subgroup with intermediate risk, and with C-reactive protein levels in patients with high risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion.<\/jats:title>\n                    <jats:p>Many patients with PsA have clinical estimated intermediate or high risk of a fatal CV event. A carotid US study detects subclinical vascular disease and may be useful to depict the real risk. The presence of atheroma is only partially explained by the classic CV risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.181223","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T12:25:10Z","timestamp":1560601510000},"page":"682-689","source":"Crossref","is-referenced-by-count":12,"title":["Role of Carotid Ultrasound and Systematic Coronary Risk Evaluation Charts for the Cardiovascular Risk Stratification of Patients with Psoriatic Arthritis"],"prefix":"10.3899","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4837-5237","authenticated-orcid":false,"given":"Mar\u00eda Paz","family":"Mart\u00ednez-Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0219-9055","authenticated-orcid":false,"given":"Mariano","family":"Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vega","family":"Jovan\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Santos-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Romera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-4944","authenticated-orcid":false,"given":"Cristina","family":"Fern\u00e1ndez-Carballido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"key":"2020050109252803000_47.5.682.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401021"},{"key":"2020050109252803000_47.5.682.2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N"},{"key":"2020050109252803000_47.5.682.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.03.019"},{"key":"2020050109252803000_47.5.682.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2004.07.010"},{"key":"2020050109252803000_47.5.682.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.02.012"},{"key":"2020050109252803000_47.5.682.6","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","volume":"11","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"2020050109252803000_47.5.682.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.05.001"},{"key":"2020050109252803000_47.5.682.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775"},{"key":"2020050109252803000_47.5.682.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00114-3"},{"key":"2020050109252803000_47.5.682.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs092"},{"key":"2020050109252803000_47.5.682.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.07.008"},{"key":"2020050109252803000_47.5.682.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090667"},{"key":"2020050109252803000_47.5.682.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100668"},{"key":"2020050109252803000_47.5.682.14","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.22884","article-title":"High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"15","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2020050109252803000_47.5.682.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2007.11.011"},{"key":"2020050109252803000_47.5.682.16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.593244"},{"key":"2020050109252803000_47.5.682.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.628875"},{"key":"2020050109252803000_47.5.682.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.075"},{"key":"2020050109252803000_47.5.682.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203101"},{"key":"2020050109252803000_47.5.682.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.01.012"},{"key":"2020050109252803000_47.5.682.21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203433"},{"key":"2020050109252803000_47.5.682.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"key":"2020050109252803000_47.5.682.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1885-5857(07)60188-1"},{"key":"2020050109252803000_47.5.682.24","doi-asserted-by":"publisher","DOI":"10.1159\/000343145"},{"key":"2020050109252803000_47.5.682.25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jbspin.2017.07.002","article-title":"Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid ultrasound","volume":"85","author":"Mart\u00ednez-Vidal","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2020050109252803000_47.5.682.26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206824"},{"key":"2020050109252803000_47.5.682.27","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2015.1031822"},{"key":"2020050109252803000_47.5.682.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.12.002"},{"key":"2020050109252803000_47.5.682.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2743-7"},{"key":"2020050109252803000_47.5.682.30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/acr.22536","article-title":"Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study","volume":"67","author":"Ernste","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2020050109252803000_47.5.682.31","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s10067-016-3362-2","article-title":"Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study","volume":"35","author":"Ahmed","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2020050109252803000_47.5.682.32","doi-asserted-by":"publisher","DOI":"10.1186\/ar4271"},{"key":"2020050109252803000_47.5.682.33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00296-016-3614-0","article-title":"Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study","volume":"37","author":"Nissen","year":"2017","journal-title":"Rheumatol Int"},{"key":"2020050109252803000_47.5.682.34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/RHU.0000000000000306","article-title":"Rates of cardiovascular disease and major adverse cardiovascular events in patients with psoriatic arthritis compared to patients without psoriatic arthritis","volume":"21","author":"Li","year":"2015","journal-title":"J Clin Rheumatol"},{"key":"2020050109252803000_47.5.682.35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210275"},{"key":"2020050109252803000_47.5.682.36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209315"},{"key":"2020050109252803000_47.5.682.37","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2470"},{"key":"2020050109252803000_47.5.682.38","doi-asserted-by":"crossref","first-page":"e3596","DOI":"10.1097\/MD.0000000000003596","article-title":"Midlife ankylosing spondylitis increases the risk of cardiovascular diseases in males 5 years later: a national population-based study","volume":"95","author":"Hung","year":"2016","journal-title":"Medicine"},{"key":"2020050109252803000_47.5.682.39","first-page":"358","article-title":"Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factors","volume":"46","author":"Apra\u015f Bilgen","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2020050109252803000_47.5.682.40","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case-control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"key":"2020050109252803000_47.5.682.41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080646"},{"key":"2020050109252803000_47.5.682.42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205267"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.181223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T12:25:56Z","timestamp":1588335956000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.181223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5,1]]}},"alternative-id":["10.3899\/jrheum.181223"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.181223","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]}}}